Cosmetic Surgery May Help Patients Quit Smoking
If you’re a smoker considering cosmetic surgery, your plastic surgeon will likely require you to stop smoking for at least two weeks before your procedure. A long-term follow-up study finds that many patients receiving these instructions will quit smoking, or at least smoke less, in the years after cosmetic surgery, reports the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
“Our results show an association between cosmetic surgery and smoking cessation at long-term follow-up,” said lead author Aaron C. Van Slyke, MD, MSc, of University of British Columbia, Vancouver. “Surgeons who request preoperative smoking cessation may influence patients’ long-term smoking status.”
Many Cosmetic Surgery Patients Quit or Reduce Smoking
The follow-up study included 85 patients who were smokers when evaluated for cosmetic surgery. Like most plastic surgeons, senior author Nicholas J. Carr, MD, required all patients from his cosmetic surgery practice to refrain from smoking for at least two weeks before elective procedures. Those instructions reflect a well-demonstrated increase in wound healing problems and other negative outcomes among smokers after plastic surgery.
Five years after cosmetic surgery, 47 patients responded to a follow-up survey. Most of the patients were women; the average age was 40 years. The most common procedures were tummy tuck (abdominoplasty), breast lift (mastopexy), and facelift. After exclusion of five social smokers, the study included 42 patients who were daily smokers before cosmetic surgery.
In the follow-up survey, about 40 percent of patients said they no longer smoked cigarettes on a daily basis. Nearly one-fourth had not smoked at all since their cosmetic surgery procedure.
Most patients said they had reduced their cigarette use by any amount. Seventy percent agreed that discussing their increased surgical risks with the plastic surgeon influenced their ability to quit or reduce smoking.
However, one-half of patients admitted they did not follow the instructions to refrain from cigarette use before surgery. Nearly one-fourth continued to smoke up to the day of their procedure. Dr. Van Slyke and colleagues did not test to confirm whether patients had stopped smoking.
The complication rate after cosmetic surgery was higher in patients who continued to smoke: 24 percent versus 14 percent. (The difference was not statistically significant.) More serious wound-healing complications occurred in two patients, both of whom did not follow the instructions to stop smoking.
Due to the negative effects of smoking on wound healing, many plastic surgeons are unwilling to perform cosmetic surgery procedures in patients who smoke. Compared to studies in other groups, the new findings suggest that cosmetic surgery patients seem more likely to quit or cut back on smoking at long-term follow-up.
“This is consistent with previous research showing patients who seek to obtain cosmetic surgery are more motivated to sustain positive lifestyle changes,” Dr. Van Slyke said.
The results suggest that patients were more motivated to quit by targeted messaging with specific examples of the negative effects of smoking, rather than by a description of the general health benefits of smoking cessation. The authors conclude, “The dialogue between plastic surgeon and patient during the cosmetic surgery consultation serves as a unique moment to provide targeted smoking cessation counseling that may persist well beyond the surgical interaction.”
Click here to read “Perioperative and Long-Term Smoking Behaviors in Cosmetic Surgery Patients”
Article: “Perioperative and Long-Term Smoking Behaviors in Cosmetic Surgery Patients” (doi: 10.1097/PRS.0000000000003604)
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.